Nomogram for 5-year relapse-free survival of a patient with advanced gastric cancer after surgery
- PMID: 27664559
- DOI: 10.1016/j.ijsu.2016.09.080
Nomogram for 5-year relapse-free survival of a patient with advanced gastric cancer after surgery
Abstract
Background: Prognoses vary substantially among patients with advanced gastric cancer following curative surgery. The aim of the current study was to develop and verify the validity of a novel nomogram that predicts the probability of 5-year relapse-free survival (RFS) in patients who underwent curative resection for stage II/III gastric cancer.
Materials and methods: A nomogram to predict 5-year RFS following surgical resection of gastric cancer was constructed based on the data of patients who underwent surgery for primary gastric carcinoma at three institutions in Japan in January 2001-December 2006. Multivariate analysis using a Cox proportional hazards regression model was performed, and the nomogram's predictive accuracy (discrimination) and the agreement between observed outcomes and predictions (calibration) were evaluated by internal validation.
Results: Multivariate analyses revealed that age at operation, depth of tumor, tumor location, lymph node classification, and presence of combined resection were significant prognostic factors for RFS. In the internal validation, discrimination of the developed nomogram for 5-year RFS was superior to that of the American Joint Committee on Cancer TNM classification (concordance indices of 0.80 versus 0.67; P < 0.001). Moreover, calibration appeared to be accurate. Based on these results, we have created free software to more easily predict 5-year RFS.
Conclusion: We developed and validated a nomogram to predict 5-year RFS after curative surgery for stage II/III gastric cancer. This tool will be useful for the assessing a patient's individual recurrence risk when considering additional therapy in clinical practice.
Keywords: Advanced gastric cancer; Cox proportional hazards regression model; Nomogram; Prediction; Recurrence risk.
Copyright © 2016 IJS Publishing Group Ltd. Published by Elsevier Ltd. All rights reserved.
Similar articles
-
Development and external validation of a nomogram for overall survival after curative resection in serosa-negative, locally advanced gastric cancer.Ann Oncol. 2014 Jun;25(6):1179-84. doi: 10.1093/annonc/mdu125. Epub 2014 Mar 24. Ann Oncol. 2014. PMID: 24669009
-
A novel nomogram individually predicting disease-specific survival after D2 gastrectomy for advanced gastric cancer.Cancer Commun (Lond). 2018 May 15;38(1):23. doi: 10.1186/s40880-018-0293-0. Cancer Commun (Lond). 2018. PMID: 29764518 Free PMC article.
-
Lymph nodes ratio based nomogram predicts survival of resectable gastric cancer regardless of the number of examined lymph nodes.Oncotarget. 2017 Jul 11;8(28):45585-45596. doi: 10.18632/oncotarget.17276. Oncotarget. 2017. PMID: 28489596 Free PMC article.
-
Staging, nomograms and other predictive tools in retroperitoneal soft tissue sarcoma.Chin Clin Oncol. 2018 Aug;7(4):36. doi: 10.21037/cco.2018.08.01. Chin Clin Oncol. 2018. PMID: 30173527 Review.
-
Survival prediction tools for esophageal and gastroesophageal junction cancer: A systematic review.J Thorac Cardiovasc Surg. 2018 Aug;156(2):847-856. doi: 10.1016/j.jtcvs.2018.03.146. Epub 2018 Apr 12. J Thorac Cardiovasc Surg. 2018. PMID: 30011772
Cited by
-
Nomogram for predicting the survival of gastric adenocarcinoma patients who receive surgery and chemotherapy.BMC Cancer. 2020 Jan 6;20(1):10. doi: 10.1186/s12885-019-6495-2. BMC Cancer. 2020. PMID: 31906882 Free PMC article.
-
A Prognostic Model for Patients With Gastric Signet Ring Cell Carcinoma.Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211027912. doi: 10.1177/15330338211027912. Technol Cancer Res Treat. 2021. PMID: 34190015 Free PMC article.
-
Family history of malignant tumor is a predictor of gastric cancer prognosis: Incorporation into a nomogram.Medicine (Baltimore). 2022 Sep 2;101(35):e30141. doi: 10.1097/MD.0000000000030141. Medicine (Baltimore). 2022. PMID: 36107576 Free PMC article.
-
Low PARP-1 expression level is an indicator of poor prognosis in patients with stage II and III gastric cancer.J Cancer. 2022 Jan 1;13(3):869-876. doi: 10.7150/jca.65145. eCollection 2022. J Cancer. 2022. PMID: 35154455 Free PMC article.
-
Nomogram to Predict Recurrence and Guide a Pragmatic Surveillance Strategy After Resection of Hepatoid Adenocarcinoma of the Stomach: A Retrospective Multicenter Study.Ann Surg Oncol. 2023 May;30(5):2942-2953. doi: 10.1245/s10434-022-12757-w. Epub 2022 Nov 9. Ann Surg Oncol. 2023. PMID: 36352297
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical